Skip to main content
. 2021 May 24;12:21501327211018559. doi: 10.1177/21501327211018559

Table 2.

Comorbidities.

Total (N = 1169)
Baseline hypertension, n (%)
 No 965 (82.5)
 Yes 204 (17.5)
Baseline CAD, n (%)
 No 1110 (95.0)
 Yes 59 (5.0)
Baseline arrhythmia, n (%)
 No 1122 (96.0)
 Yes 47 (4.0)
Baseline CHF, n (%)
 No 1139 (97.4)
 Yes 30 (2.6)
Baseline DLP, n (%)
 No 982 (84.0)
 Yes 187 (16.0)
Baseline diabetes, n (%)
 No 1038 (88.8)
 Yes 131 (11.2)
Baseline stroke/CVD, n (%)
 No 1152 (98.5)
 Yes 17 (1.5)
Baseline asthmatic, n (%)
 No 1081 (92.5)
 Yes 88 (7.5)
Baseline COPD, n (%)
 No 1092 (93.4)
 Yes 77 (6.6)
Baseline chronic liver disease, n (%)
 No 1125 (96.2)
 Yes 44 (3.8)
Baseline CKD, n (%)
 No 1124 (96.2)
 Yes 45 (3.8)
Baseline PUD, n (%)
 No 1167 (99.8)
 Yes 2 (0.2)
Baseline rheumatoid arthritis, n (%)
 No 1158 (99.1)
 Yes 11 (0.9)
Baseline osteoporosis, n (%)
 No 1151 (98.5)
 Yes 18 (1.5)
Baseline cancer, n (%)
 No 1109 (94.9)
 Yes 60 (5.1)
Baseline HIV, n (%)
 No 1168 (99.9)
 Yes 1 (0.1)
Baseline autism, n (%)
 No 1167 (99.8)
 Yes 2 (0.2)
Baseline dementia, n (%)
 No 1134 (97.0)
 Yes 35 (3.0)
Baseline depression, n (%)
 No 942 (80.6)
 Yes 227 (19.4)
Baseline schizophrenia, n (%)
 No 1163 (99.5)
 Yes 6 (0.5)
Baseline anxiety, n (%)
 No 953 (81.5)
 Yes 216 (18.5)
Baseline SAD, n (%)
 No 1155 (98.8)
 Yes 14 (1.2)